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accumulation is negatively regulated by Mdm2, which targets it for ubiquitin-mediated proteasome degradation; Mdm2 is, in turn, negatively regulated by p19 ARF [for review see (13;14) ]. E2F1 induces the expression of p19 ARF (15) , thus directly connecting the Rb/E2F
pathway to p53 accumulation and an apoptotic response ( Figure 2 ). However, E2F1 can also induce apoptosis in a p53 independent manner, which could be attributed, at least in part, to the activation of a p53 family member p73. E2F1 was shown to activate transcription of the p73 gene and both E2F1 and p73 were required for the p53 independent apoptosis observed in peripheral T cells (16;17) . In addition, E2F1 has been shown to specifically induce expression of Apafl (18) , which in combination with cytosolic cytochrome C and the caspase 9 protease forms the so-called apoptosome. This ternary complex then activates the downstream caspase proteases that are the final effectors of cell death ( Figure 2 ).
Further evidence for a unique role for E2F1 in an apoptotic response is seen from the observation that E2F1 is specifically induced following DNA damage (19) . p53 is also induced upon DNA damage , and its induction involves the ATM and ATR protein kinases, which are activated by DNA damage, and then target p53 directly or indirectly through the Chk2 kinase [for review, see (20) ]. The phosphorylation of p53 by ATM/ATRthen blocks the ability of Mdm2 to target p53 destruction. The induction of E2F1 in response to DNA damage similarly involves the ATM and related ATR protein kinases (21) (Figure 2 ). The ATM/ATR kinases phosphorylate E2F1 and this phosphorylation also blocks the proteasome-mediated degradation of E2F1. The specificity of ATM and ATR for E2F1, rather than other E2F proteins, reflects a unique phosphorylation site within the N terminal domain of E2F1 that overlaps with sequence shown to be important for degradation. Presumably, this induction of E2F1 in response to DNA damage 6 provides for a synergistic activation of p53 through the activation of p19 ARF , or contributes to p53-independent apoptosis, possibly via activation of p73 ( Figure 2 ).
The c-Myc transcription factor
A variety of studies demonstrate that tight regulation of Myc protein levels is essential for normal cell function. Myc expression is regulated at multiple levels. Myc RNA expression is controlled by both cell growth associated increases in myc gene transcription and an increase in myc mRNA stability (22) . Recent work has demonstrated that Myc protein expression is not only regulated by new synthesis, dependent upon its mRNA levels, but also by cell growth related from Cyclin E, which leads to the inactivation of Cyclin E/Cdk2 complexes (36;37). Myc expression also strongly down-regulates the p27 Cyclin kinase inhibitor (30) .
Myc overexpression has also been reported to induce E2F DNA binding activity (38) . 
Ras signaling pathways
The Ras activity also stimulates transcription of the cyclin kinase inhibitor p21 and p16
INK4a
, which could underlie the ability of Ras to induce cellular senescence (61) . In contrast, Ras activation has been shown to down-regulate the p27kip1 CKI, resulting in the activation of Cyclin E/Cdk2 (62) . The down-regulation of p27 involves both the ERK and PI3-K effector signaling pathways, and it is associated with a decrease in the rate of p27 translation, stability and association with Cyclin E/Cdk2, and this is essential for Ras-mediated entry into S phase (63) .
Ras, via Raf, has also been reported to activate the Cdc25A phosphatase that removes inhibitory phosphates from Cdk2 and Cdk4 contributing to their activation (64) . Taken together, these data place Ras upstream of the G1 Cdk/Rb/E2F pathway.
Connecting Ras with Myc
One Then, as the cell cycle progresses and AKT activity falls, GSK-3 becomes active leading to the phosphorylation of Threonine 58 and the increased degradation of Myc. As such, Myc protein levels decline later in G1 and then persists at this level as a cell continues to grow. While this regulation of Myc stability appears complex, it allows for precise timing and controlled levels of Myc expression.
Alterations in G1 signaling pathways in cancer
Lesions in the Rb/E2F, Myc, and Ras pathways occur in virtually all human tumors described to date [for reviews, see (45;72;73) ]. As discussed in this review, each of these pathways plays an important role in the control of both cellular proliferation as well as apoptosis.
Moreover, recent evidence demonstrates that extensive cross-talk exists between these cell regulatory pathways (see Figure 4) . 
